Australia markets close in 4 hours 33 minutes

VYNE Therapeutics Inc. (VYNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.73000.0000 (0.00%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-29,079
-28,452
-23,210
-73,329
-255,568
-
Depreciation & amortisation
-
0
72
109
341
-
Stock-based compensation
3,434
3,305
4,297
8,080
18,100
-
Change in working capital
-1,168
60
2,277
4,776
-40,331
-
Accounts receivable
-689
405
11,210
7,709
-17,138
-
Inventory
-
0
97
113
-6,048
-
Accounts payable
-659
-559
-8,681
-2,675
-
481
Other working capital
-27,845
-25,341
-29,200
-56,367
-137,195
-
Other non-cash items
-
-
-
2,472
84,072
-
Net cash provided by operating activities
-27,845
-25,341
-29,200
-56,367
-137,082
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-113
-11
Purchases of investments
-77,523
-62,354
0
-
0
-83,397
Sales/maturities of investments
-
-
0
1,027
50,579
124,782
Net cash used for investing activities
-65,923
-57,354
15,667
1,027
89,107
-
Cash flows from financing activities
Debt repayment
-
-
0
-36,432
0
-
Common stock issued
82,665
82,821
1,470
75,981
61,639
-
Common stock repurchased
0
-360
-
-
-
-
Other financing activities
-
-
-
-294
-141
-
Net cash used provided by (used for) financing activities
82,607
82,394
1,653
39,777
61,808
-
Net change in cash
-11,161
-301
-11,880
-15,563
13,833
-
Cash at beginning of period
30,280
30,975
42,855
58,418
44,584
-
Cash at end of period
19,119
30,674
30,975
42,855
58,418
-
Free cash flow
Operating cash flow
-27,845
-25,341
-29,200
-56,367
-137,082
-
Capital expenditure
-
-
-
-
-113
-11
Free cash flow
-27,845
-25,341
-29,200
-56,367
-137,195
-